Jan 8, 2025 · Medicare drug plans can now cover Eli Lilly 's blockbuster obesity drug Zepbound for obstructive sleep apnea, CNBC confirmed on Wednesday. That opens the door for broader access to Zepbound,...

In a statement to CNBC, a spokesperson for the Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services, said "current Medicare Part D and Medicaid coverage rules apply" to Zepbound following its landmark approval in December for the most common sleep-related breathing disorder.

Jan 10, 2025 · Popular Eli Lilly (LLY) weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and Drug Administration (FDA) approval last month.

Jan 3, 2025 · Zepbound is the first medication for obstructive sleep apnea to receive FDA approval . This breakthrough for sleep apnea treatment received FDA approval in December 2024 and can be prescribed to adults who have both obesity and moderate to …

Jan 12, 2025 · CMS announced that Medicare drug plans (Part D or Medicare Advantage) could now cover Zepbound (tirzepatide) when doctors prescribe it to patients for obesity and sleep apnea. This is not the opening of floodgates. It is movement from an absolute “no” to “maybe.”

3 days ago · Does Medicare Cover Zepbound? Medicare coverage can be complex, and it varies based on specific plans and individual circumstances. Generally, Medicare Part B may cover certain medications administered in a clinical setting, while Part D covers outpatient prescriptions.

Jan 8, 2025 · Zepbound met that new criteria last month after the FDA approved it as the first prescription medication to address moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. It...

Jan 9, 2025 · Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, broadening access to the blockbuster weight-loss treatment.

Jan 9, 2025 · Eli Lilly's obesity drug Zepbound (tirzepatide) can now be covered by Medicare insurance plans for use in sleep apnea, broadening access to the weight-loss treatment.

Zepbound met that new criteria last month after the FDA approved it as the first prescription medication to address moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. It...